Thus, these results suggest that intensive insulin therapy starting from the onset of diabetes might prevent the development of abnormalities of the GH-IGF-I-IGFBP-3 axis, likely allowing normal IGF-I and IGFBP-3 levels and physiological growth in children and adolescents with T1D [58]. This evidence concerns the gene INS and type 1 diabetes mellitus.